-
Experts Will Untangle Complexities of Mixed Connective Tissue Disease in Great Debate
Judith James, MD, PhD, Oliver Distler, MD, and other experienced clinical investigators, including Lisa Christopher-Stine, MD, MPH, will present the evidence for and against this rare systemic autoimmune disease being a distinct disease entity.
-
Review Course Delves into Both Rare and Common Clinical Considerations
Review Course co-chairs Julie Paik, MD, MHS, and Noelle A. Rolle, MBBS, FACR, FACP, provide an overview of the eight featured lectures in this advance programming covering topics across the spectrum of rheumatology.
-
Speakers to Examine Pregnancy Termination and LGBTQ+ Care for Patients with Rheumatic Disease
Bonnie Bermas, MD, and Kristen Mathias, MD, will highlight the interplay of reproductive health and rheumatology while detailing the unique challenges faced by this patient population in receiving optimal care.
-
Artificial Intelligence and Novel Indications for Hypoglycemic Agents Among Hot Topics for Rheumatology Clinicians
Tracy Frech, MD, MS, Chair of the Clinical Science Team for the Annual Meeting Planning Committee, gives an overview of the clinical science program at ACR Convergence 2024, including Meet the Panel and Meet the Professor sessions.
-
Sessions on Young Patients Prioritize Interactive, Collaborative Learning
The pediatric program continues to expand, said Susan Shenoi, MD, MS, Chair of the Pediatric Team for the Annual Meeting Planning Committee. A new addition this year is a game-based Engage and Solve session focused on juvenile idiopathic arthritis and rare diseases in pediatric rheumatology.
-
Expand Your Network
ACR Convergence is full of opportunities to engage with friends and colleagues, and to establish new connections within the rheumatology community, including Networking Lounges, the ACR Career Fair, and the Poster Hall.
-
Basic & Clinical Research Conference to Explore Dynamics of Inflammation and Cardiovascular Risk
French investigator and clinician Pierre Miossec, MD, PhD, will deliver the keynote address of the Basic & Clinical Research Conference, tracing the discovery of IL-17 almost 30 years ago and reviewing how this key cytokine affects skin joint targets and the link between cardiovascular disease…
-
Experts to Explain Why CAR-T Cell Therapy Is Promising But Not a Cure-All
One of the key questions for this therapy is the durability of CAR-T response in autoimmune diseases, which Anca Askanase, MD, MPH, and George Tsokos, MD, will discuss in a session on the history and future of cellular therapy in rheumatic diseases.
-
FDA to Review New Rheumatology Approvals, Safety Messaging, Programs
Timely communication of evolving safety information is a critical element in providing the best care for patients. Representatives from the U.S. Food and Drug Administration, including Amit Golding, MD, PhD, will give an update on safety issues in the treatment of rheumatic diseases.
-
Sessions Will Explore Imminent Applications and Future Landscape of AI Tools in Rheumatology Clinical Care, Education, and Research
Artificial intelligence (AI) is not going to replace rheumatologists now or in the foreseeable future; however, using AI to help patients, improve clinic workflows, and facilitate research is forthcoming, says Bella Mehta, MD. Multiple sessions at ACR Convergence will highlight the potential of this technology.